Bacterial Profiles in Hemoptysis Patients by Lung Disease Type, 2021-2025

A retrospective review of 188 patients who underwent bronchial artery embolization for hemoptysis at a tertiary referral center between January 2021 and December 2025. The dataset, authored by Ui Won Ko and shared on figshare, stratifies patients by structural lung disease and reports bacterial identification results from respiratory specimens. It shows distinct pathogen profiles, such as Pseudomonas aeruginosa being more frequent in patients with bronchiectasis.

Use Cases

• Compare bacterial prevalence based on structural lung disease categories mentioned in the description.
• Inform empirical antibiotic selection strategies for hemoptysis patients using the reported pathogen profiles.
• Analyze associations between specific bacteria (e.g., Pseudomonas aeruginosa, Klebsiella pneumoniae) and disease phenotypes like bronchiectasis or emphysema.
• Validate clinical hypotheses about infection triggers in patients undergoing bronchial artery embolization.

Strengths

• Includes 188 patient records with clear stratification into three structural lung disease categories.
• Reports specific bacterial identification results and statistical comparisons (e.g., 29.2% vs. 1.4% for P. aeruginosa).
• Data covers a defined 5-year time range from 2021 to 2025.

Limitations

• Row count for the underlying data table is unknown, which may limit suitability assessment.
• Column-level documentation is absent; field semantics must be inferred after download.
• The dataset is very small at 12.8 KB, indicating limited scope.

Provenance

Source

figshare, author Ui Won Ko.

Collection Method

Retrospective review of consecutive patients at a tertiary referral center; bacterial evaluation used standard cultures and multiplex polymerase chain reaction.

Time Range

January 2021 to December 2025.

Freshness

Last updated 2026-05-29 06:07:17; freshness should be verified.